AbbVie CEO Richard Gonzalez's 2021 pay stays at $24M
AbbVie reports 2021 executive compensation
By ExecPay News
Published: March 21, 2022
AbbVie reported fiscal year 2021 executive compensation information on March 21, 2022.
In 2021, five AbbVie executives received on average a compensation package of $14M, a 20% decrease compared to previous year.
Average pay of disclosed executives at AbbVie
Richard A. Gonzalez, Chief Executive Officer, received $24M in total, which is about the same as previous year. 53% of Gonzalez's compensation, or $13M, was in stock awards. Gonzalez also received $781K of change in pension value and nonqualified deferred compensation earnings, $4.9M in non-equity incentive plan, $3.1M in option awards, $1.7M in salary, as well as $814K in other compensation.
For fiscal year 2021, the median employee pay was $149,662 at AbbVie. Therefore, the ratio of Richard A. Gonzalez's pay to the median employee pay was 160 to one.
Laura J. Schumacher, Chief Legal Officer, received a compensation package of $12M, which decreased by 28% compared to previous year. 34% of the compensation package, or $4.3M, was in stock awards.
Robert A. Michael, Chief Financial Officer, earned $12M in 2021, a 14% decrease compared to previous year.
Michael E. Severino, Chairman, received $11M in 2021, which decreases by 18% compared to 2020.
Jeffrey R. Stewart, Executive Vice President, Chief Commercial Officer, earned $9M in 2021.
Related executives
You may also like
Source: SEC filing on March 21, 2022.